Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endometrial gene expression during ovarian stimulation with recombinant FSH vs recombinant FSH + LH in poor responders
2022-002310-16Phase 4Completed
- Sponsor
- UZ Brussel
- Start
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of follitropin alfa and lutropin alfa in female infertility (2 arms), sponsored by UZ Brussel. Primary endpoint: Endometrial gene expression profile by RNA sequencing. Started Dec 2022; status: completed.
02
Drugs
follitropin alfalutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on 2022-002310-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002310-16.